We are delighted to announce the launch of our eBook – ‘Regulatory Requirements for IND Applications in the United States (US).’ Our comprehensive eBook offers insights into the significance of an IND application, the timelines for its submission to the US Food and Drug Administration (FDA), and the essential information and data that sponsors and drug manufacturers must include in their submissions.
Navigating IND submissions is crucial for ensuring the safety and efficacy of new drugs. Our eBook aims to help sponsors/drug manufacturers comply with the FDA guidelines while developing innovator drugs within the United States.
Fill the form below to download the e-Book
